Remus Pharmaceuticals Limited — Important, 17-05-2025: General Updates

Remus Pharmaceuticals has announced a board meeting on May 17, 2025, approving a 1:1 bonus share issue, doubling equity shares from 58.92 lakh to 1.18 crore. The bonus will be issued from Rs. 5.89 Cr of free reserves, raising paid-up capital to Rs. 11.78 Cr. The company holds Rs. 44.08 Cr in free reserves available for capitalization. Bonus shares are expected to be credited within 60 days, pending shareholder approval.